FDA Inspection
VitalantVitalant – FDA Inspection, Sep 20, 2011
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on September 20, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- September 20, 2011
- Product Type
- Biologics
View Company Profile
ID · d51f7f24-e882-42e6-af52-4a36250ddd6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 746605
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 25, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 30, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 30, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1221124 - 2023-10-24
- FDA Inspection 1076516 - 2018-12-19
- FDA Inspection 1028490 - 2017-08-25
- FDA Inspection 927824 - 2015-04-30
- FDA Inspection 818297 - 2013-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.